Does THC Treatment for Tourette Syndrome Cause Cognitive Problems? | Research

The takeaway

A small randomized trial found that a single dose of THC for Tourette syndrome did not impair memory, reaction time, attention, or intelligence, contrary to concerns based on recreational cannabis use studies.

Read this if you have Tourette syndrome and want to know whether THC treatment might affect your thinking or memory.

No cognitive impairment across 7 domains in 12 Tourette patients given THC

What the researchers found

In 12 adult Tourette syndrome patients given a single dose of 5-10 mg THC or placebo, researchers found no significant differences in verbal memory, visual memory, reaction time, intelligence, sustained attention, divided attention, vigilance, or mood. The only notable finding was a potential worsening of obsessive-compulsive behavior measured by one questionnaire, though the authors cautioned this particular instrument had known limitations for measuring that outcome.

A trend toward increased phobic anxiety was also observed, which the researchers attributed to the single-dose design that prevented gradual dose titration. The authors concluded that, unlike findings in healthy recreational cannabis users, therapeutic THC doses did not cause cognitive impairment in Tourette syndrome patients.

Why it matters

One of the major concerns about using THC therapeutically is the potential for cognitive side effects. This study provided early evidence that cognitive impairment observed in recreational users may not apply to patients using THC for specific medical conditions, potentially because the therapeutic context, dose, and patient population differ from recreational use scenarios.

The numbers in context

Twelve patients participated. THC doses ranged from 5.0 to 10.0 mg as a single administration. No significant differences were found across any of the primary cognitive measures between THC and placebo conditions.

How the study worked

This was a randomized, double-blind, placebo-controlled crossover trial. Twelve adult Tourette syndrome patients received either a single dose of THC (5-10 mg) or placebo, then crossed over to the other condition. A comprehensive battery of neuropsychological tests assessed multiple cognitive domains. The Symptom Checklist 90-R was used to assess behavioral and mood changes.

What this study cannot tell us

The sample size of 12 patients was small and limited statistical power to detect subtle cognitive effects. Only a single dose was tested, so the cognitive safety of longer-term THC treatment remains unaddressed by this study. The crossover design, while efficient, can be complicated by carryover effects. The increase in obsessive-compulsive behavior scores is difficult to interpret given the acknowledged limitations of the assessment tool used.

How to read the evidence

This is a randomized, double-blind, placebo-controlled crossover trial, though limited by its small sample size of 12 patients.

When this study was published

Published in 2001. Subsequent research has continued to investigate cannabinoids for Tourette syndrome with larger samples.

The bigger picture

This study was part of a growing body of research suggesting THC could be beneficial for Tourette syndrome tics and behavioral symptoms. The finding that therapeutic doses did not impair cognition helped address a key safety concern that could otherwise limit clinical adoption. Subsequent larger trials have continued to explore cannabinoids for Tourette syndrome.

Questions still open

Would longer-term daily THC treatment for Tourette syndrome maintain cognitive safety? Does the absence of cognitive impairment relate to the lower doses used therapeutically, or to some characteristic of Tourette syndrome patients specifically?

Common questions

Can THC help with Tourette syndrome tics?

This and other studies from the same research group found evidence that THC reduced tics in Tourette syndrome patients. This particular study focused on whether that treatment came with cognitive side effects, finding that it did not at therapeutic doses.

Why might THC affect cognition differently in Tourette patients than recreational users?

The researchers suggested that differences in dose (therapeutic vs. recreational), administration context, and possibly the underlying neurochemistry of Tourette syndrome could all contribute to different cognitive outcomes.

Read the original research

Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol (delta9-THC) on neuropsychological performance.

Pharmacopsychiatry, 34(1), 19-24

View on PubMed ↗

Citation

Müller-Vahl, K R; Koblenz, A; Jöbges, M; Kolbe, H; Emrich, H M; Schneider, U. (2001). Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol (delta9-THC) on neuropsychological performance.. Pharmacopsychiatry, 34(1), 19-24.